Summary
This European Society of Ophthalmology guidance document addresses the escalating global burden of myopia, projected to affect 4.9 billion people by 2050. The paper synthesises evidence on myopia aetiology, epidemiology, and risk factors, and reviews both preventive strategies and treatment options to reduce myopia onset and slow progression. The guidance is intended to inform clinical decision-making and public health responses to what may become the leading cause of irreversible vision impairment globally.
UK applicability
The guidance is directly applicable to UK ophthalmology practice and NHS service provision. UK practitioners and policymakers can reference this European consensus to implement myopia control programmes and preventive strategies aligned with international best practice.
Key measures
Prevalence projections of myopia globally and in Europe; effectiveness of myopia control interventions; risk factors for myopia onset and progression
Outcomes reported
The study summarises current evidence on myopia pathogenesis, genetics, epidemiology, and risk factors, and reviews preventive and treatment options for myopia management. It provides clinical guidance on myopia control interventions to prevent onset and slow progression.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.